Fargo residents learned that Imricor Medical Systems, a Burnsville, Minnesota company that makes cardiac ablation products, will retain a $1,158,000 North Dakota Bioscience Innovation grant even though its planned manufacturing facility in Fargo never materialized. The finding comes from a state audit released this week.
According to the North Dakota Department of Agriculture, the grant was the largest of the 39 awards given in 2023 and 2024, totaling $10.9 million in state funding. Recipients collectively spent $8.4 million, with the balance returned to the state. Imricor’s proposal called for $8.8 million in project costs and promised to repurpose a 15,000‑square‑foot office in the metro area, creating 20 high‑paying technical positions.
Commissioner Doug Goehring said the grant was awarded because Imricor met the statutory requirements: registration in North Dakota, fewer than $2.5 million in sales, and at least two employees. He noted that the law authorizing the grant does not obligate a company to maintain a physical presence in the state. “They met the requirement to be eligible, and they followed through and created and did what they said they would do, so why wouldn’t they be reimbursed?” Goehring told The Forum.
State Auditor Josh Gallion disagreed, arguing that the purpose of the grant is to foster a bioscience industry and jobs in North Dakota. “When you talk about operating, and when you look at the purpose of this grant, it seems like this is to help foster and create a bioscience industry in North Dakota,” Gallion said.
The audit also revealed that almost half of the $8.4 million spent went to recipients that never established a physical location in the state, though the report does not name those companies. It further noted that the Agriculture Department did not conduct site visits or require performance reviews, and that the agency lacked authority to enforce compliance.
Goehring called the audit “misleading and disingenuous,” suggesting it was “clickbait” aimed at stirring public anger. He defended the department’s track record, saying, “Our programs have always worked.” Gallion defended his team’s work, stating, “I think my team did excellent work. Everything in here is supported. Every conclusion is documented in our work papers.”
Imricor filed paperwork on Nov. 11, 2025, withdrawing its registration as a North Dakota business, and the Secretary of State now lists the company as inactive. The Greater Fargo‑Moorhead Economic Development Corp. and North Dakota State University had previously engaged with Imricor, but NDSU spokeswoman Jennifer Burris said the company has not been in contact since 2023.
While the grant remains with Imricor, the audit’s findings may prompt legislative review of the Bioscience Innovation Grant program to ensure future awards deliver on their promise of local jobs and economic growth.
Sources: inforum.com, inforum.com